We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » cGMP Violations Lead to Warning Letter for Brazilian Company
cGMP Violations Lead to Warning Letter for Brazilian Company
Mappel Industria, a Brazil-based company received a warning letter from the FDA due to significant violations of cGMP regulations for finished pharmaceuticals.